Masimo Shareholders Approve $180 Cash Acquisition by Danaher

Masimo shareholders approved a $180 cash acquisition by Danaher, marking a significant move in the healthcare industry. The acquisition price was $180 per share.

According to reports, shareholders of Masimo have given the green light to its acquisition by Danaher in a cash deal. The move is valued at $180 per share. With the necessary approvals secured, the $10 billion merger between the two companies is reportedly nearing completion.

The news has significant implications for the healthcare industry as the acquisition will strengthen Danaher's presence in the medical technology sector.

While details of the merger agreement terms were supported by Masimo shareholders, further information on the completion of the acquisition is expected in the coming days.

Masimo Shareholders Approve $180 Cash Acquisition by Danaher

Related Stocks